1. Home
  2. GDOT vs CTMX Comparison

GDOT vs CTMX Comparison

Compare GDOT & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Green Dot Corporation $0.001 par value

GDOT

Green Dot Corporation $0.001 par value

HOLD

Current Price

$13.39

Market Cap

724.4M

Sector

Finance

ML Signal

HOLD

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

HOLD

Current Price

$3.75

Market Cap

642.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GDOT
CTMX
Founded
1999
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
724.4M
642.2M
IPO Year
2010
2015

Fundamental Metrics

Financial Performance
Metric
GDOT
CTMX
Price
$13.39
$3.75
Analyst Decision
Sell
Strong Buy
Analyst Count
2
10
Target Price
$11.00
$12.10
AVG Volume (30 Days)
544.8K
5.3M
Earning Date
05-14-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.33
N/A
Revenue
$2,080,491,000.00
$76,201,000.00
Revenue This Year
$11.07
N/A
Revenue Next Year
$5.69
$7.61
P/E Ratio
$40.45
$22.58
Revenue Growth
20.69
N/A
52 Week Low
$9.31
$1.72
52 Week High
$15.41
$8.21

Technical Indicators

Market Signals
Indicator
GDOT
CTMX
Relative Strength Index (RSI) 59.23 63.57
Support Level $12.75 $3.76
Resistance Level $13.73 $3.90
Average True Range (ATR) 0.25 0.22
MACD 0.03 0.12
Stochastic Oscillator 63.64 92.27

Price Performance

Historical Comparison
GDOT
CTMX

About GDOT Green Dot Corporation $0.001 par value

Green Dot Corp is a financial technology company that provides financial services for consumers in the United States without good banking options. It has three segments Consumer Services, Business to Business Services(B2B), and Money Movement Services. The company generates maximum revenue from B2B segment. Its B2B Services segment consists of revenues and expenses derived from (i) its partnerships with prominent consumer and technology companies that make banking products and services available to their consumers, partners and workforce through integration with its banking platform (the "Banking-as-a-Service", or "BaaS channel"), and (ii) a comprehensive payroll platform that it offers to corporate enterprises (the "Employer channel") to facilitate payments for todays workforce.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: